A Trial of Ipatasertib in Combination With Atezolizumab
Clinical trial NCT03673787 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03673787
- Sponsor
- Institute of Cancer Research, United Kingdom
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-13
- Primary completion
- 2026-03-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.